Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors.
Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors.
复制标题
DOI：
10.1002/pon.5399
复制
发表时间：
2020-12
期刊：
影响因子：
3.6
通讯作者：
Sterba KR
中科院分区：
文献类型：
--
作者：
Graboyes EM;Maurer S;Park Y;Marsh CH;McElligott JT;Day TA;Hornig JD;Sterba KR
本研究旨在评估BREAT(在头颈癌治疗后重建形象)的可行性、可接受性和初步临床影响，BREAT是一种基于远程医学的认知行为干预措施，用于管理头颈癌(HNC)幸存者的身体形象障碍(BID)。有BID的HNC幸存者被招募参加单臂飞行员试验。参与者在基线、BREAT后1个月和3个月完成研究测量，以评估其可接受性和临床影响。参与者完成了半结构化访谈，以评估BREAT的可行性和可接受性，并改进干预措施。有BID的10名HNC幸存者参加了基于片剂的BLANT试验。Bright是可行的，根据低辍学率(n=1)、高疗程完成率(100%；45/45)和基于平板电脑的低技术问题发生率(11%的次要问题；0%的主要问题)来判断。90%的参与者非常有可能推荐Bright，这反映了它的可接受性。BREAT组在BIGH后1个月的平均体像评分下降了34.5%(与基线的平均差异=4.56；95%可信区间1.55，7.56)，这种效应在光明后3个月持续存在(平均较基线下降=3.56；95%可信区间为1.15至5.96)。计划评估显示，对Bright的满意度很高，特别是交付平台。在定性评估中，参与者强调明亮改善了与图像相关的应对行为。BREAT是可行的，HNC幸存者可以接受，并且作为一种管理HNC幸存者BID的新方法具有显著的潜力。有必要进行更多的研究，以提炼BREAT并评估其临床疗效和可扩展性。
The study aimed to evaluate the feasibility, acceptability, and preliminary clinical impact of BRIGHT (Building a Renewed ImaGe after Head & neck cancer Treatment), a novel telemedicine-based cognitive-behavioral intervention to manage body image disturbance (BID) in head and neck cancer (HNC) survivors. HNC survivors with BID were enrolled into a single-arm pilot trial. Participants completed study measures at baseline, 1- and 3-months post-BRIGHT to assess its acceptability and clinical impact. Participants completed semi-structured interviews to evaluate the feasibility and acceptability of BRIGHT and refine the intervention. Ten HNC survivors with BID were enrolled into the trial of tablet-based BRIGHT. BRIGHT was feasible, as judged by low dropout (n=1), high session completion rates (100%; 45/45) and low rates of technical issues with the tablet-based delivery (11% minor; 0% major). Ninety percent of participants were highly likely to recommend BRIGHT, reflecting its acceptability. BRIGHT was associated with a 34.5% reduction in mean Body Image Scale scores at 1-month post-BRIGHT (mean difference from baseline = 4.56; 95% CI 1.55, 7.56), an effect that was durable at 3-months post-BRIGHT (mean decrease from baseline = 3.56; 95% CI 1.15 to 5.96). Program evaluation revealed high levels of satisfaction with BRIGHT, particularly the delivery platform. During the qualitative evaluation, participants highlighted that BRIGHT improved image-related coping behavior. BRIGHT is feasible, acceptable to HNC survivors, and has significant potential as a novel approach to manage BID in HNC survivors. Additional research is necessary to refine BRIGHT and evaluate its clinical efficacy and scalability.
登录
查看更多内容
影响因子：
4.7
作者：
Fingeret, Michelle Cororve;Teo, Irene;Goettsch, Keelan
通讯作者：
Goettsch, Keelan
DOI：
10.1002/hed.21181
发表时间：
2010-03-01
影响因子：
2.9
作者：
Fingeret, Michelle Cororve;Vidrine, Damon J.;Gritz, Ellen R.
通讯作者：
Gritz, Ellen R.
影响因子：
3.6
作者：
Chen, Shu-Ching;Huang, Bing-Shen;Lai, Yeur-Hur
通讯作者：
Lai, Yeur-Hur
影响因子：
45.3
作者：
Esplen, Mary Jane;Wong, Jiahui;Toner, Brenda
通讯作者：
Toner, Brenda
影响因子：
8.4
作者：
Hopwood, P;Fletcher, I;Ghazal, SA
通讯作者：
Ghazal, SA